Nowa wersja platformy, zawierająca wyłącznie zasoby pełnotekstowe, jest już dostępna.
Przejdź na https://bibliotekanauki.pl
Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 23

Liczba wyników na stronie
first rewind previous Strona / 2 next fast forward last
Wyniki wyszukiwania
help Sortuj według:

help Ogranicz wyniki do:
first rewind previous Strona / 2 next fast forward last
EN
Elevated homocysteine is a risk factor in cardiovascular diseases and neurodegeneration. Among the putative mechanisms of homocysteineevoked neurotoxicity, disturbances in methylation processes and NMDA receptor-mediated excitotoxicity have been suggested. Our previous studies demonstrated that group I metabotropic glutamate receptors along with NMDA receptors participate in acute homocysteine-induced neuronal damage. In this study, using propidium iodide staining, we tested whether the same mechanism may mediate chronic homocysteine neurotoxicity. Our results confirmed that the application of D,L-homocysteine in micromolar concentrations for 3 days induces neurodegeneration in primary cultures of cerebellar granule neurons. Uncompetitive NMDA receptor antagonist MK801, and mGlu1 or mGlu5 receptor antagonists (LY367385 and MPEP, respectively), given alone provided very limited neuroprotection. However, simultaneous application of the NMDA receptor antagonists MK-801, memantine or amantadine and MPEP almost completely prevented chronic homocysteine neurotoxicity. These findings suggest a novel therapeutic strategy to combat neurodegeneration induced by hyperhomocysteinemia comprising a combination of antagonists of group I metabotropic glutamate receptors and NMDA receptors.
EN
BACKGROUND AND AIMS: Brominated flame retardant tetrabromobisphenol A (TBBPA) contaminates the environment and displays cytotoxic potential. The mechanism of its cytotoxicity in neurons encompasses interference with NMDA and ryanodine receptors (NMDARs and RyRs) resulting in increase in intracellular Ca2+ concentration (Ca2+i), and induction of oxidative stress, which may be primary, or secondary to rises in Ca2+i. The aim of this study was to assess the role of excitotoxicity and Ca2+ imbalance in TBBPA-evoked oxidative stress and cytotoxicity in neurons. METHODS: Using the primary cultures of rat cerebellar granule cells (CGC) we evaluated oxidative stress induced by an acute challenge with 10 or 25 µM TBBPA by measuring reactive oxygen species (ROS) production, intracellular glutathione (GSH) level, SOD-1 and SOD-2 level, catalase activity, and the level of Zn2+ in CGC. Zn2+ and Ca2+i were measured fluoromertically, moreover TBBPA toxicity 24 h after the exposure was evaluated using propidium iodide staining. The pharmacological tools included NMDARs antagonist MK-801, ryanodine with bastadin 12 inhibiting RyRs, and various free radical scavengers. RESULTS: TBBPA induced concentration-dependent decrease in CGC viability, increase in Ca2+i and Zn2+ level, in ROS production, decrease in GSH level, catalase activity and SOD-2 level. Co-application of NMDARs and RyRs inhibitors which completely prevented increase in Ca2+i, resulted in a significant, but not complete cytoprotection, and only partially reduced the oxidative stress in the CGC. Also administration of ROS scavengers provided only partial cytoprotection and reduction of oxidative stress. CONCLUSIONS: We conclude that the production of free radicals resulting secondarily from TBBPA-evoked excitotoxicity and increases in Ca2+ level together with oxidative stress possibly induced primarily by TBBPA, both participate in TBBPA cytotoxicity in cultured neurons. Supported by the NCN grant 2012/05/B/NZ7/03225.
EN
Silver nanoparticles (NAg) possess antibacterial properties thus are widely used in many applications in medicine, life sciences and biotechnology. Nanoparticles can be found in vertebrate brain, but little is known about their neurotoxicity. The aim of this study was to investigate how NAg can contribute to neuronal cell death. In the study primary cultures of rat cerebellar granule cells (CGC) were used. We tested hypothesis concerning the role of glutamatergic NMDA receptors in NAg-evoked neurotoxicity. In our study changes in intracellular calcium (Ca2+) homeostasis, uptake of 45Ca2+, reactive oxygen species (ROS) production, mitochondrial membrane potential and cells viability were investigated. We used commercially available 0.2% polyvinylpyrrolidone (PVP)-coated NAg <100 nm. To avoid sedimentation and agglomeration, before application to the CGC culture, NAg were sonicated with fetal calf serum. NAg were applied in concentration 2.5–75 µg/ml for 10, 30 min or 24 h, depending on experiment. As a pharmacological tool 0.5 µM MK801, a noncompetitive inhibitor of NMDA receptor, was used. After 10 min incubation in the presence of 25–75 µg/ ml NAg dose dependent increase of 45Ca2+ concentration was observed in neurons. This increase was comparable to that evoked by 100 µM glutamate and was completely abolished by MK801. Using fluorescent intracellular calcium indicator fluo3 we observed increase in intracellular calcium level by 200% compared to control, which was partially diminished by MK801. ROS production was measured using fluorescent dye DCF. After 30 min incubation with 75 µg/ml NAg the increase by about 35% over control level was observed and application of MK801 reduced it significantly. Changes in mitochondrial membrane potential were determined using rhodamine (R123). We observed significant decrease in mitochondrial potential during 30 min incubation with different concentrations of NAg and also in this case administration of MK801 was protective. Cells viability was assessed after 24 h incubation with NAg µg/ml alone or together with MK801. Application of MK801 increased neuronal survival from 50% up to 80%. Our results show that excitotoxicity via activation of NMDA receptor, followed by calcium imbalance, destabilization of mitochondrial function and ROS production, seems to be important mechanism involved in neurotoxicity evoked by NAg in cultured neurons. Supported by grant NN401619938.
EN
Nicotinamide is an important cofactor in many metabolic pathways and a known neuroprotective substance, while its methylated product, 1-methylnicotinamide, is a suspected neurotoxin. Homocysteine is a risk factor in Alzheimer’s disease and neurodegeneration, causing inhibition of methylation processes and inducing excitotoxicity. In this study, using primary cultures of rat cerebellar granule cells and propidium iodide staining, we investigated the neurotoxicity of nicotinamide and 1-methylnicotinamide, and their neuroprotective potential in acute and sub-acute homocysteine neurotoxicity. Our results demonstrated that nicotinamide and 1-methylnicotinamide applied for 24 h to cultures at concentrations of up to 25 mM had no effect on neuronal viability. Moreover, nicotinamide at concentrations of 5–20 mM and 1-methylnicotinamide at 1–10 mM applied to cells 24 h before, and for 24 h after an acute 30 min application of 25 mM D,L homocysteine, reduced neuronal damage. 1-Methylnicotinamide at concentrations of 250 and 500 µM showed neuroprotective activity during a sub-acute 24-h exposure to 2.5 mM D,L-homocysteine, while 5 and 25 mM nicotinamide also evoked neuroprotection. These findings do not support suggestions that 1-methylnicotinamide may act as an endogenous neurotoxic agent; rather, they indicate the neuroprotective ability of nicotinamide and 1-methylnicotinamide in homocysteine neurotoxicity. The exact mechanisms of this neuroprotection are unclear and require further investigation.
EN
In experiments we used indocyanine green (ICG), and gadobutrol (Gad) contrast dyes. There is no information about parallel application of ICG and Gad, therefore we decided to study their toxicity using primary cerebellar granule cells culture (CGC). The aim of study was to assess the minimal ICG concentration which evokes neurotoxicity. 30 min exposition to 75 and 125 μM ICG resulted in neurotoxicity. We observed imbalance in calcium homeostasis (extra- and intracellular) after addition of ICG, which can be one of the mechanisms of ICG neurotoxicity. We measured absorbance and NMR spectra for 25–125 µM ICG concentrations in three solvents. Gad contrast media mixed with ICG were also measured and neurotoxicity of this mixture was examined. The shape of absorption and NMR spectra show differences between water, water with 2.3 mM Ca2+ and Locke25 for all analyzed ICG concentrations. Other possible mechanism of ICG neurotoxicity can be dose dependent oligomerization of ICG. We did not observe any toxic effect of Gad on CGC. Protective effect on surviving neurons after treatment of ICG, dependent on Gad dose and sequence of its administration (before > simultaneously > after addition of ICG) was observed. However, the mechanism of this phenomenon remains not clear. Supported by grant 2011/03/B/ST7/02576.
EN
BACKGROUND AND AIMS: The results of early studies suggested a role of glutamate receptors in the mechanism of increases in intracellular Ca2+ concentration ([Ca2+]i ) and cytotoxicity induced by the brominated flame retardant, tetrabromobisphenol-A (TBBPA). Although now interest has focused mainly on TBBPA-induced Ca2+ release from intracellular stores, here we revisited the former issue and tested the involvement of NMDA receptors (NMDARs) in Ca2+ imbalance in neurons induced by TBBPA. METHODS: These effects were examined in primary cultures of rat cerebellar granule cells (CGC), and then, using isolated cortical membranes we checked whether TBBPA directly interacts with the agonist and modulatory sites of the NMDAR complex. On the 7th day in vitro CGC were treated with TBBPA at low µM concentrations. 45Ca uptake was detected and changes in [Ca2+]i , and plasma membrane potential were measured using fluorescent probes fluo-3 and oxonol VI, respectively. Moreover effects of TBBPA on specific binding of [3 H]MK-801, [3 H]glutamate and [3 H]glycine to isolated fraction of the rat brain cortex membranes were studied. RESULTS: The results demonstrated that TBBPA concentrationdependently increased 45Ca uptake and [Ca2+]i in CGC, and the increase was partially inhibited by NMDARs antagonist, MK-801. This effect was additive to glutamate-induced Ca2+ transients. TBBPA increased oxonol VI fluorescence in CGC reflecting depolarization of the cultured neurons. The binding assays demonstrated potentiation by TBBPA binding of [ 3 H]MK-801 in the presence of NMDA and glycine, with maximum at 20 µM TBBPA, which was inhibited by spermidine and antagonists of the polyamines’ site; inhibition by TBBPA of [ 3 H]glutamate binding, and no significant effect on [3 H]glycine binding. CONCLUSIONS: TBBPA directly enhances the activity of NMDARs in neuronal membranes by interfering with their modulatory sites, and by inducing depolarization of neurons. Supported by the NCN grant 2012/05/B/NZ7/03225
EN
There are alarming reports on cytotoxicity of the brominated flame retardant tetrabromobisphenol A (TBBPA) in the in vitro cellular models, that seem to be mediated by increases in the intracellular calcium concentration ([Ca2+] i) and oxidative stress. Still, the mechanisms of both these phenomena, their mutual cause‑and‑effect relationships and implication in the TBBPA-induced neuronal death are not clear. In our experiments the primary cultures of rat cerebellar granule cells (CGC) were acutely challenged with TBBPA. Such induced rises of [Ca2+]i appeared to result independently from the intracellular Ca2+ release via ryanodine receptors transformed into dysfunctional leak channels, and from Ca2+ influx mediated by NMDA receptors. These receptors seem to be activated indirectly, due to depolarization of neurons by TBBPA, which is mediated by the voltage-gated sodium channels and ionotropic glutamate receptors. TBBPA induced oxidative stress as evidenced by ROS production and decrease in GSH content and catalase activity. The pharmacological preventing of the TBBPA-induced rises in [Ca2+]i also entirely prevented oxidative stress induced by 10 µM TBBPA, while the effects of 25 µM TBBPA were only partially reduced. Application of free radical scavengers significantly reduced TBBPA‑induced oxidative stress, but did not interfere with rises in [Ca2+]i. This indicates that TBBPA-induced increase in [Ca2+]i is a primary and major event triggering oxidative stress, however at higher µM concentrations a Ca2+‑independent portion of oxidative stress emerges, and this effect seems to be directly induced by TBBPA. Furthermore, the separate application of inhibitors of TBBPA-induced Ca2+ transients and free radical scavengers, both provided a strong but incomplete cytoprotection, whereas combination of these substances completely prevented the death of neurons, showing that Ca2+ imbalance and oxidative stress are the triggers of acute TBBPA toxicity in CGC. FINANCIAL SUPPORT: This study was supported by the Polish National Science Centre grant no. 2012/05/B/ NZ7/03225.
EN
Controlled fl uctuations in intracellular calcium concentrations play an important role in many cellular processes such as muscle contraction, secretion, metabolism, and neuronal function. Ryanodine receptors (RyR) are intracellular ion channels that mediate the release of calcium ions from internal stores and have been suggested as pharmacological targets for heart disease and neurodegenerative diseases. Bastadins are an ever-growing family of marine natural products isolated from sponges. Seemingly subtle differences in their substitution pattern suffi ce to alter the response observed. To characterize bastadin-induced changes in calcium homeostasis we measured, using FLUO-3, a calciumsensitive fl uorescent probe, the ability of bastadin 5 (positive control) and the acyclic analogues 2a, b and 4 to increase the intracellular calcium concentration in cultured rat cerebellar granule cells. We monitored also the infl ux of extracellular calcium to neurons employing 45Ca isotope. The observed effect of the acyclic analogues on calcium accumulation decreased in order: 4>2b>2a. Addition of ryanodine to medium before application of bastadin abolished analyzed effects. This observation indicates that RyR are the primary targets for their pharmacological activity. Thus, the infl ux of extracellular calcium to bastadin-treated neurons appears to be a secondary effect resulting from the release of calcium from the ryanodine-sensitive pool. Constraining the catechol aryl ether moiety of bastadins by incorporation into a macrocyle is not necessary in order to mimic the effects of these marine natural products on neuronal calcium homeostasis. Simple, acyclic analogues that embody the ìwesternî or ìeasternî parts of bastadins were found to evoke comparable responses with bastadin 5.
EN
INTRODUCTION: The disorders of the glutamatergic neurotransmission have been implicated in the pathogenesis of autism, but data on brain content of glutamate (Glu) in patients and animal models are inconsistent. AIM(S): Aim of this study is to evaluate changes in the brain content of Glu, glutamine (Gln) and GABA in the rat models of pharmacologically-induced autism. METHOD(S): The rat females at the 11th day of gestation were given orally 800 mg/kg b.w. of valproic acid (VPA) or 500 mg/kg b.w. of thalidomide (THAL). The pups at PND 9 were submitted to ultrasonic vocalization (USV) test, and at PND 30, under anesthesia, to in vivo unilateral microdi alysis of the hippocampus with a calcium-containing medium. The samples of dialysate representing the basal level followed by a 40 min pulse of 100 mM KCl were collected. The contralateral hippocampi were prepared and homogenized. After derivatization of the amino acids with o-phtalaldehyde, the samples were submitted to HPLC analysis with a fluorescence detection. RESULTS: The results of USV tests showed that the pups prenatally treated with VPA, and to a greater extent with THAL, less frequently produced USV calls, which is regarded as impairment in social communication, a symptom characteristic of autism. In the male rats of the VPA and THAL groups, a total content of Glu increased to 143% and 158%, respectively, and also Gln and GABA contents were significantly elevated. All these values remained unchanged in the female rats. Basal levels of Glu, Gln and GABA in the dialysates of the hippocampi in the experimental groups did not differ from controls, however in VPA‑treated male rats during application of 100 mM KCl a reduction by 59% of Gln concentration and tendency to increase GABA level were found. CONCLUSIONS: The results demonstrate increased content of glutamate in the hippocampus of rats in two chemical models of autism, support a hypothesis on the role of the glutamatergic disturbances in the pathogenesis of autism. FINANCIAL SUPPORT: This study was supported by the Polish National Science Centre, grant no. 2014/15/B/ NZ4/04490.
EN
Thimerosal (TH), an ethylmercury complex of thiosalicylic acid has been used as preservative in vaccines. Inspired by a known high affi nity of mercury for thiol groups, we examined whether the presence of L-cysteine (Cys), D,L-homocysteine (Hcy), Nacetyl cysteine (NAC), L-methionine (Met) and glutathione (GSH) in extracellular space could infl uence the viability, intracellular calcium concentration ([Ca2+]i ) and mitochondrial membrane potential in rat cerebellar granule cells. The cells were exposed to 500 nM TH for 48 h or 15 μM TH for 10 min. The loss of cells viability could be prevented partially or wholly, in a dose-dependent manner, by 60, 120 or 600 μM Cys, Hcy, NAC and GSH, but not by Met. The elevation in [Ca2+]i and mitochondrial potential induced by 25 μM TH were abolished by all compounds studied, except for Met, at 600 μM. The loss of the ethylmercury moiety from TH as a result of interaction with thiols studied was monitored by 1 Hand 199Hg-NMR spectroscopy. This extracelullar process may be responsible for the neuroprotection seen in cerebellar cell culture, but also provides a molecular pathway for redistribution of TH derived toxic ethylmercury in the organism.
EN
We investigated if the cGMP/cCGP-dependent protein kinase (PKG) signaling pathway was involved in 1-methyl-4-phenylpyridinium (MPP+)-induced cPLA2 activation of dopaminergic neuronal cells (PC12 cells). We found increased levels of total and phosphorylated cPLA2 and increased AA release in the nigrostriatal system of MPTPinduced parkinsonism mice and in PC12 cells exposed to MPP+. We used cPLA2-specifi c inhibitors and Ca2+-independent PLA2 (iPLA2), and we found that cPLA2 released more AA after stimulation with MPTP/MPP+ than iPLA2 and that there was a time-dependent delay of AA release by iPLA2 compared to cPLA2. The PKG inhibitor KT5823 decreased MPTP-induced AA release in the nigrostriatal pathway. KT5823, in addition to PKC and ERK1/2 inhibitors, decreased cPLA2 activity as well as total and phosphorlyated cPLA2 protein levels in the midbrain and striatum of MPTP-induced parkinsonism mice. Inhibition occurred within 30 minutes and persisted for up to 24 hours. Similar results were also observed in MPP+-treated PC12 cells. Dual treatment with PKG and PKC inhibitors had the same effect on cPLA2 activity and protein levels. PKG is involved in the enhancement of cPLA2 phosphorylation at Serine-505 and in AA release in PC12 cells exposed to MPP+. In PC12 cells, inhibitors of cPLA2 and PKG increased viability and prevented MPP+-induced apoptosis. Our results indicate that the nNOS/cGMP/PKG pathway stimulates cPLA2 phosphorylation at Ser-505 by activation of PKC or ERK1/2. Our results also suggest that upregulation of the nNOS/cGMP pathway observed in experimental models of PD may mediate dopaminergic neuron degeneration and death through activation of cPLA2. This work was supported by MSHE, Scientifi c Network nr. 28/E32/SN-0053/2007
first rewind previous Strona / 2 next fast forward last
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.